Email this article Dipeptide mimetic of the bdnf loop 4 possesses analgetic activity
- Authors: Gudasheva T.A.1, Konstantinopolsky M.A.1, Tarasiuk A.V.1, Kolik L.G.1, Seredenin S.B.1
-
Affiliations:
- Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
- Issue: Vol 485, No 3 (2019)
- Pages: 366-369
- Section: Biochemistry, biophysics, molecular biology
- URL: https://journals.eco-vector.com/0869-5652/article/view/12886
- DOI: https://doi.org/10.31857/S0869-56524853366-369
- ID: 12886
Cite item
Full Text
Abstract
Previously, we synthesized a dimeric dipeptide mimetic of the brain-derived neurotrophic factor (BDNF) loop 4, GSB-106, which, similarly to BDNF, activated TrkB, PI3K/AKT, and MAPK/ERK. When administered systemically, it exhibited neuroprotective, antidepressant, and antidiabetic activities and stimulated neurogenesis and synaptogenesis. In this study, we established that GSB-106 also exhibits the analgesic activity, typical for BDNF, which was revealed in rats in hot plate and tail flick tests 0.5–48 h after intraperitoneal injection at doses of 0.1 and 1 mg/kg.
Keywords
About the authors
T. A. Gudasheva
Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
Author for correspondence.
Email: tata-sosnovka@mail.ru
corresponding member of the RAS
Russian Federation, MoscowM. A. Konstantinopolsky
Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
Email: tata-sosnovka@mail.ru
Russian Federation, Moscow
A. V. Tarasiuk
Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
Email: tata-sosnovka@mail.ru
Russian Federation, Moscow
L. G. Kolik
Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
Email: tata-sosnovka@mail.ru
Russian Federation, Moscow
S. B. Seredenin
Zakusov State Foundation Institute of Pharmacology of the Russian Academy of Medical Sciences
Email: tata-sosnovka@mail.ru
academician of the RAS
Russian Federation, MoscowReferences
- Kaplan D. R., Miller F. D. // Curr. Opin. Neurobiol. 2000. V. 10. P. 381-391.
- Autry A. E., Monteggia L. M. // Pharmacol. Rev. 2012. V. 64. № 2. P. 238-258.
- Thoenen H., Sendtner M. // Nat. Neurosci. 2002. V. 5. P. 1046-1050.
- Robinson R. C., Radziejewski C., Stuart D. I., Jones E. Y. // Biochemistry. 1995. V. 34. № 13. P. 4139-4146.
- Гудашева Т. А., Тарасюк А. В., Помогайбо С. В., Логвинов И. О., Поварнина П. Ю., Антипова Т. А., Сере- денин С. Б. // Биоорг. химии. 2012. Т. 38. № 3. С. 280-290.
- Гудашева Т. А., Тарасюк А. В., Сазонова Н. М., По- варнина П. Ю., Антипова Т. А., Середенин С. Б. // ДАН. 2017. Т. 476. № 1. С. 108-112.
- Gudasheva T. A., Povarnina P.Yu., Logvinov I. O., Antipova T. A., Seredenin S. B. // Drug Des. Develop. Ther. 2016. № 10. P. 3545-3553.
- Середенин С. Б., Воронина Т. А., Гудашева Т. А., Гарибова Т. Л., Молодавкин Г. М., Литвинова С. А., Елизарова О. А., Посева В. И. // Acta Natur. 2013. Т. 5. № 4. С. 116-120.
- Таллерова А. В., Поварнина П. Ю., Блынская Е. В., Буева В. В., Гудашева Т. А., Середенин С. Б. // Хим.- фарм. журн. 2018. Т. 52. № 5. С. 15-17.
- Гудашева Т. А., Поварнина П. Ю., Середенин С. Б. // БЭБиМ. 2016. Т. 162, № 9. С. 448-451.
- Gudasheva T. A., Povarnina P.Yu., Antipova T. A., Seredenin S. B. // Doklady Biochemistry and Biophysics. 2018. V. 481. P. 225-227.
- Островская Р. У., Ягубова С. С., Гудашева Т. А., Се- реденин С. Б. // БЭБиМ. 2017. Т. 164. № 12. С. 701705.
- Siuciak J. A., Altar C. A., Wiegand S. J., Lindsay R. M. // Brain Res. 1994. V. 633. № 1/2. P. 326-330.
- Siuciak J. A., Wong V., Pearsall. D., Wiegand S. J., Lindsay R. M. // Eur. J. Neurosci. 1995. V. 7. № 4. P. 663670.
- Le Bars D., Gozariu M., Cadden S. W. // Pharmacol. Rev. 2001. V. 53. № 4. P. 597-652.
Supplementary files
